Does Nilotinib Capsule Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SLT ANTINEOPLASTIC SYSTEMIC ENZYME INHIB/ST JOHN'S WORT
- SELECTED IMMUNOSUPPRESSANTS/NADOFARAGENE FIRADENOVEC
- MODERATE CYP3A4 INHIBITORS/DARIDOREXANT (>25 MG)
- MODERATE CYP3A4 INHIBITORS/LUMATEPERONE (>21 MG)
- MODERATE CYP3A4 INHIBITORS/MITAPIVAT (> 20 MG)
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- NILOTINIB/PIMOZIDE
- STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (> 50 MG)
- SELECTED CYP3A4 MODERATE INHIBITORS/LURASIDONE (> 80 MG)
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- SELECTED IMMUNOSUPPRESSANTS/TALIMOGENE LAHERPAREPVEC
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (> 12.5 MG)
- MODERATE CYP3A4 INHIBITORS/RANOLAZINE (> 500 MG BID)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (> 50 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- SELECTED IMMUNOSUPPRESSIVE AGENTS/LIVE VACCINES; LIVE BCG
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/EFALIZUMAB; NATALIZUMAB
- UGT1A1 INHIBITORS/IRINOTECAN
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED KINASE INHIBITORS/PROTON PUMP INHIBITORS
- NILOTINIB/QT PROLONGING AGENTS
- SLT ANTINEO SYSTEMIC ENZYME INHIBITORS/FLUCONAZOLE
- SELECTED ANTINEOPLASTICS THAT PROLONG QT/SAQUINAVIR
- NILOTINIB/STRONG CYP3A4 INHIBITORS
- NILOTINIB/STRONG CYP3A4 INHIBITORS THAT PROLONG QT
- ANTINEOPLASTIC SYST ENZYME INH THAT INHIBIT 3A4/CARBAMAZEPIN
- ANTINEOPLASTIC SYST ENZYME INHIBITORS/APALUTAMIDE
- SLT ANTINEOPLASTIC SYSTEMIC ENZYME INH/LUMACAFTOR-IVACAFTOR
- NILOTINIB/VONOPRAZAN-CLARITHROMYCIN
- SELECTED KINASE INHIBITORS/VONOPRAZAN
- NILOTINIB/STRONG CYP3A4 INDUCERS
- CYP3A4 INHIBITORS AND SUBSTRATES THAT PROLONG QT/ENCORAFENIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- STRONG AND MODERATE CYP3A4 INHIBITORS/REPOTRECTINIB
- IMMUNOSUPPRESSIVE 3A4 INHIBITORS THAT PROLONG QT/ETRASIMOD
- MODERATE CYP3A4 INHIBITORS/LURBINECTEDIN
- SELECTED MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- NILOTINIB/IVOSIDENIB
- MODERATE CYP3A4 INHIBITORS/COLCHICINE (FOR CARDIOPROTECTION)
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/RITLECITINIB
- MODERATE CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- MODERATE CYP3A4 INHIBITORS/PEXIDARTINIB
- MODERATE CYP3A4 INHIBITORS/MAVACAMTEN
- MODERATE CYP3A4 INHIBITORS THAT PROLONG QT/PACRITINIB
- MODERATE 3A4 INHIBITORS THAT PROLONG QT/MOBOCERTINIB
- UGT INHIBITORS/LORAZEPAM EXTENDED RELEASE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/CLADRIBINE
- IMMUNOSUPPRESSIV; IMMUNOMODULATORS THAT PROLONG QT/SIPONIMOD
- IMMUNOSUPPRESSIVES;IMMUNOMODULATORS THAT PROLONG QT/OZANIMOD
- IMMUNOSUPPRES;IMMUNOMODULATORS THAT PROLONG QT/FINGOLIMOD
- IMMUNOSUPPRESSIV;IMMUNOMODULATORS THAT PROLONG QT/PONESIMOD
- STRONG & MODERATE 3A4 INHIBITOR THAT PROLONG QT/FEXINIDAZOLE
- MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FILGOTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- SELECTED MODERATE CYP3A4 INHIBITORS/ALPRAZOLAM
- SELECTED IMMUNOSUPPRESSANTS/LEFLUNOMIDE; TERIFLUNOMIDE
- MODERATE CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/PRALSETINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/BARICITINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/INEBILIZUMAB
- MODERATE CYP3A4 INHIBITORS THAT PROLONG QT/SELPERCATINIB
- MODERATE CYP3A4 INHIBITORS/PEXIDARTINIB (200 MG)
- MODERATE CYP3A4 INHIBITORS THAT PROLONG QT/IVABRADINE
- UGT1A1 INHIBITORS/SACITUZUMAB GOVITECAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- MODERATE CYP3A4 INHIBITORS/TAZEMETOSTAT
- MYELOSUPPRESSIVE AGENTS THAT PROLONG QT/CLOZAPINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- MODERATE CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- STRONG & MOD CYP3A4 INHIBITOR THAT PROLONG QT/ORAL LEFAMULIN
- MODERATE CYP3A4 INHIBITORS THAT PROLONG QT/ENTRECTINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UPADACITINIB
- MODERATE CYP3A4 INHIBITORS/BRIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIB;MODERATE 3A4 & P-GP DUAL INHIB/NERATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- MODERATE CYP3A4 INHIBITORS/VENETOCLAX
- IMMUNOSUPPRES;IMMUNOMODUL/SELECTED MULTIPLE SCLEROSIS AGENTS
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (<= 12.5 MG)
- MODERATE CYP3A4 INHIBITORS/COBIMETINIB; OLAPARIB; SONIDEGIB
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- MODERATE CYP3A4 INHIBITORS/SUVOREXANT (> 10 MG)
- STRONG UGT1A1 INHIBITORS/BELINOSTAT
- MODERATE CYP3A4 INHIBITORS/ERGOT ALKALOIDS
- POSSIBLE QT PROLONGING AGENTS/ANAGRELIDE
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- STRONG AND MODERATE CYP3A4 INHIBITORS/BOSENTAN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOFACITINIB
- MODERATE CYP3A4 INHIBITORS/BOSUTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
- SELECTED MYELOSUPPRESSIVE AGENTS/DEFERIPRONE
- MODERATE CYP3A4 INHIBITORS/COLCHICINE
- POSSIBLE QT PROLONGING AGENTS/DRONEDARONE
- MODERATE CYP3A4 INHIBITORS/TOLVAPTAN
- POSSIBLE QT PROLONGING AGENTS/ARTEMETHER-LUMEFANTRINE
- POSSIBLE QT PROLONGING AGENTS/DISOPYRAMIDE
- POSSIBLE QT PROLONGING AGENTS/CISAPRIDE
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- POSSIBLE QT PROLONGING AGENTS/SERTINDOLE
- POSSIBLE QT PROLONGING AGENTS/DROPERIDOL
- POSSIBLE QT PROLONGING AGENTS/LEVOMETHADYL
- POSSIBLE QT PROLONGING AGENTS/SPARFLOXACIN
- POSSIBLE QT PROLONGING AGENTS/HALOFANTRINE
- POSSIBLE QT PROLONGING AGENTS/BEPRIDIL
- SELECTED MODERATE CYP3A4 INHIBITORS/EPLERENONE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED KINASE INHIBITORS/ANTACIDS
- NILOTINIB/POSSIBLE QT PROLONGING AGENTS
- SELECTED KINASE INHIBITORS/H2 ANTAGONISTS
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- MODERATE CYP3A4 INHIBITORS/MACITENTAN
- MODERATE CYP3A4 INHIBITORS/FINERENONE
- MODERATE CYP3A4 INHIBITORS/CAPIVASERTIB
- SELECTED MODERATE CYP3A4 INHIBITORS/CYCLOSPORINE
- MODERATE CYP3A4 INHIBITORS THAT PROLONG QT/GEPIRONE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOCILIZUMAB
- MODERATE CYP3A4 INHIBITORS/PALOVAROTENE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UBLITUXIMAB
- MODERATE CYP3A4 INHIBITORS/LAROTRECTINIB
- QT PROLONGING AGENTS/TUCIDINOSTAT
- MODERATE CYP3A4 INHIBITORS/LUMATEPERONE (<=21 MG)
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SARILUMAB
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- MODERATE CYP3A4 INHIBITORS/MITAPIVAT (<= 20 MG)
- MODERATE CYP3A4 INHIBITORS/DARIDOREXANT (<=25 MG)
- QT PROLONGING AGENTS/TOLTERODINE
- SELECTED POSSIBLE QT PROLONGING AGENTS/INTRAVENOUS LEFAMULIN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/COVID-19 VACCINES
- QT PROLONGING AGENTS/GALANTAMINE
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/USTEKINUMAB
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- MODERATE CYP3A4 INHIBITORS THAT PROLONG QT/QUETIAPINE
- POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
- QT PROLONGING AGENTS/OSILODROSTAT
- QT PROLONGING AGENTS/AMISULPRIDE
- MODERATE CYP3A4 INHIBITORS/RIMEGEPANT
- MODERATE CYP3A4 INHIBITORS/AVAPRITINIB
- MODERATE CYP3A4 INHIBITORS/UBROGEPANT
- MODERATE & WEAK CYP3A4 INHIBITORS THAT PROLONG QT/TACROLIMUS
- MODERATE CYP3A4 INHIBITORS/ZANUBRUTINIB
- SELECTED CYP3A4 MODERATE INHIBITORS/LURASIDONE (<= 80 MG)
- QT PROLONGING AGENTS/PITOLISANT
- QT PROLONGING AGENTS/GILTERITINIB
- POSSIBLE QT PROLONGING AGENTS/GLASDEGIB
- MODERATE CYP3A4 INHIBITORS/ABEMACICLIB
- POSSIBLE QT PROLONGING AGENTS/TRAZODONE (< 100 MG)
- POSSIBLE QT PROLONGING AGENTS/LOFEXIDINE
- MODERATE CYP3A4 INHIBITORS/CABERGOLINE
- POSSIBLE QT PROLONGING AGENTS/MACIMORELIN
- SELECTED MODERATE CYP3A4 INHIBITORS/ACALABRUTINIB
- POSSIBLE QT PROLONGING AGENTS/INOTUZUMAB OZOGAMICIN
- QT PROLONGING AGENTS/EFAVIRENZ
- MODERATE CYP3A4 INHIBITORS/BROMOCRIPTINE
- POSSIBLE QT PROLONGING AGENTS/HYDROXYZINE
- POSSIBLE QT PROLONGING AGENTS/PIMAVANSERIN
- POSSIBLE QT PROLONGING AGENTS/OSIMERTINIB
- MODERATE CYP3A4 INHIBITORS/BREXPIPRAZOLE
- POSSIBLE QT PROLONGING AGENTS/LENVATINIB
- MODERATE CYP3A4 INHIBITORS/SUVOREXANT (<= 10 MG)
- POSSIBLE QT PROLONGING AGENTS/TRAZODONE (>= 100 MG)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (<= 50 MG)
- MODERATE CYP3A4 INHIBITORS/IBRUTINIB
- POSSIBLE QT PROLONGING AGENTS/BEDAQUILINE
- POSSIBLE QT PROLONGING AGENTS/SORAFENIB
- SELECTED P-GP AND WEAK CYP3A4 INHIBITORS/RIVAROXABAN
- POSSIBLE QT PROLONGING AGENTS/EZOGABINE
- POSSIBLE QT PROLONGING AGENTS/VANDETANIB
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- POSSIBLE QT PROLONGING AGENTS/ERIBULIN
- SELECTED MODERATE CYP3A4 INHIBITORS/SELECTED OPIOIDS
- POSSIBLE QT PROLONGING AGENTS/ROMIDEPSIN
- POSSIBLE QT PROLONGING AGENTS/ILOPERIDONE
- POSSIBLE QT PROLONGING AGENTS/PAZOPANIB
- POSSIBLE QT PROLONGING AGENTS/TOREMIFENE
- MODERATE CYP3A4; P-GP INHIBITORS/EVEROLIMUS
- POSSIBLE QT PROLONGING AGENTS/QUININE
- POSSIBLE QT PROLONGING AGENTS/ZUCLOPENTHIXOL
- UGT INHIBITORS/LORAZEPAM; MEXAZOLAM
- MODERATE CYP3A4 INHIBITORS/RANOLAZINE (<=500 MG BID)
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
- POSSIBLE QT PROLONGING AGENTS/AMIODARONE
- QT PROLONGING AGENTS/NORFLOXACIN
- STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (<=50MG)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.